UFP Technologies, Inc.

UFPT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $110.2M $105.0M $101.5M $100.8M $100.0M $97.8M $91.2M $97.0M
Cost of Revenue $77.1M $74.9M $75.4M $73.0M $70.4M $69.1M $68.0M $71.4M
Gross Profit $33.0M $30.1M $26.1M $27.8M $29.6M $28.7M $23.3M $25.5M
Gross Margin 30.0% 28.6% 25.7% 27.5% 29.6% 29.4% 25.5% 26.3%
Operating Expenses
Research & Development
SG&A Expense $13.9M $13.9M $13.1M $12.5M $12.3M $13.0M $11.9M $11.8M
Operating Income $18.0M $15.9M $12.7M $15.0M $17.0M $12.8M $10.9M $26.0M
Operating Margin 16.3% 15.2% 12.5% 14.9% 17.0% 13.1% 11.9% 26.8%
Interest Expense $577.0K $631.0K $754.0K $933.0K $1.1M $869.0K $873.0K $830.0K
Pretax Income $17.4M $15.3M $11.9M $14.1M $16.0M $11.9M $9.8M $25.2M
Income Tax Expense $3.8M $2.6M $285.0K $2.4M $4.1M $2.2M $1.3M $5.7M
Net Income $13.6M $12.7M $11.6M $11.7M $11.9M $9.7M $8.5M $19.5M
Net Margin 12.3% 12.1% 11.4% 11.6% 11.9% 10.0% 9.3% 20.2%
EPS (Basic) $1.77 $1.66 $1.52 $1.53 $1.56 $1.28 $1.12 $2.58
EPS (Diluted) $1.75 $1.64 $1.51 $1.52 $1.55 $1.27 $1.10 $2.56
Shares Outstanding (Basic) 7.7M 7.7M 7.6M 7.6M 7.6M 7.6M 7.6M 7.6M
Shares Outstanding (Diluted) 7.8M 7.7M 7.7M 7.7M 7.7M 7.7M 7.7M 7.6M
Dividends Per Share
← Newer Page 2 of 8 Older →